RCM
AVEO

Rotella Capital Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Rotella Capital Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,055
Closed -$13K – 631
2015
Q3 		$13K Buy
+1,055
New +$15.2K ﹤0.01% 526

Other funds holding AVEO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DVC
Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rotella Capital Management's AVEO Position: Q4 2015 in Review

Rotella Capital Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2015, closing a stake of 1,055 shares — an estimated $13K sold.

Rotella Capital Management first reported a position in AVEO in Q3 2015 and held it in 1 quarter. The position peaked at $13K in Q3 2015. 44 funds tracked by Wall St. Rank hold AVEO as of Q4 2015.

  • Rotella Capital Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Rotella Capital Management sold 1,055 AVEO Pharmaceuticals, Inc. shares in Q4 2015, an estimated $13K.
  • Rotella Capital Management first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2015 and held it in 1 quarter.
  • Rotella Capital Management's AVEO Pharmaceuticals, Inc. position peaked at $13K in Q3 2015.
  • 44 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2015.

Based on Rotella Capital Management's 13F filing for Q4 2015, filed 9 Feb 2016.